An international measure of awareness and beliefs about cancer: Development and testing of the ABC

BMJ Open

Volumn 2, Issue 6, 2012, Pages

  Simon, Alice E ^a   Forbes, Lindsay J L ^b   Boniface, David ^a   Warburton, Fiona ^b   Brain, Kate E ^c   Dessaix, Anita ^d   Donnelly, Michael ^e   Haynes, Kerry ^f   Hvidberg, Line ^g   Lagerlund, Magdalena ^h   Petermann, Lisa ⁱ   Tishelman, Carol ^h   Vedsted, Peter ^g   Vigmostad, Maria Nyre ^j   Wardle, Jane ^a   Ramirez, Amanda J ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

^d CANCER INSTITUTE NSW   (Australia)

^e QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^f CANCER EPIDEMIOLOGY CENTRE   (Australia)

^g AARHUS UNIVERSITY   (Denmark)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ Canadian Partnership Against Cancer   (Canada)

^j NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRALIA; AWARENESS AND BELIEFS ABOUT CANCER MEASURE; CANADA; CANCER RISK; CANCER SURVIVAL; CLINICAL ASSESSMENT TOOL; CONTENT VALIDITY; CROSS-SECTIONAL STUDY; DENMARK; FACE VALIDITY; FACTORIAL ANALYSIS; FEMALE; HEALTH BELIEF; HEALTH SURVEY; HUMAN; INTERVIEW; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; NEOPLASM; NORWAY; PSYCHOMETRY; QUANTITATIVE ANALYSIS; SWEDEN; TEST RETEST RELIABILITY; UNITED KINGDOM; VALIDATION STUDY;

EID: 84873138119     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2012-001758     Document Type: Article

References (35)

1. Coleman M, Forman D, Bryant H, et al. Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995-2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 2010;377:127-38.
2. Richards MA. The size of the prize for earlier diagnosis of cancer in England. Br J Cancer 2009;101(Suppl 2):s125-9.
3. Survey Research Center. Guidelines for best practice in cross-cultural wurveys. 1-8-2010. Ann Arbor, MI, Survey Research Center, Institute for Social Research, University of Michigan. 4-4-2012. http://ccsg.isr.umich.edu/pdf/ 00FullGuidelines3.pdf (accessed 29 May 2012).
4. de Bruin A, Picavet HSJ, Nossikov A.eds. Health interview surveys: towards international harmonisation of methods and instruments. WHO Regional Publications. European series 1996: No. 58. http://www.euro.who.int/data/assets/ pdffile/0017/111149/E72841.pdf (accessed 29 May 2012).
5. Wild D, Grove A, Martin M, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005;8:94-104. (Pubitemid 40525371)
6. Mullen M. Diagnosing measurement equivalence in cross-national research. J Int Bus Stud 1995;26:573-96.
7. Simon AE, Waller J, Robb K, et al. Patient delay in presentation of possible cancer symptoms: the contribution of knowledge and attitudes in a population sample from the United Kingdom. Cancer Epidemiol Biomarkers Prev 2010;19:2272-7.
8. Macleod U, Mitchell ED, Burgess C, et al. Risk factors for delayed presentation and referral of symptomatic cancer: evidence for common cancers. Br J Cancer 2009;101(Suppl 2):s92-101.
9. Robb K, Stubbings S, Ramirez A, et al. Public awareness of cancer in Britain: a population-based survey of adults. Br J Cancer 2009;101(Suppl 2):s18-23.
10. Ramirez AJ, Westcombe AM, Burgess CC, et al. Factors predicting delayed presentation of symptomatic breast cancer: a systematic review. Lancet 1999;353:1127-31. (Pubitemid 29155204)
11. Niederdeppe J, Levy AG. Fatalistic beliefs about cancer prevention and three prevention behaviors. Cancer Epidemiol Biomarkers Prev 2007;16:998-1003. (Pubitemid 46910103)
12. Powe BD, Finnie R. Cancer fatalism: the state of the science. Cancer Nurs 2003;26:454-65.
13. Stubbings S, Robb K, Waller J, et al. Development of a measurement tool to assess public awareness of cancer. Br J Cancer 2009;101(Suppl 2):s13-17.
14. Bish A, Ramirez A, Burgess C, et al. Understanding why women delay in seeking help for breast cancer symptoms. J Psychosom Res 2005;58:321-6. (Pubitemid 40910002)
15. Andersen BL, Cacioppo JT. Delay in seeking a cancer diagnosis: delay stages and psychophysiological comparison processes. Br J Soc Psychol 1995;34:33-52.
16. Richards MA. The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Br J Cancer 2009;101(Suppl 2):s1-4.
17. Park A, Clery E. British Social Attitudes, 27th Report 2010. http://www.natcen.ac.uk/study/british-social-attitudes-27th-report (accessed 29 May 2012).
18. Environics Research Group. Cancer prevention - attitudes, awareness and behaviours - a national survey of canadians. Ontario, Canada: Environics Research Group Limited, 2008.
19. Paul C, Girgis A, Wakefield M, et al. Cancer-related knowledge and practices: recommended survey items. Version 1. Newcastle, NSW, Australia: The Public Health Committee of the Cancer Council Australia, 2006.
20. Campanelli P. Testing survey auestions: new directions in cognitive interviewing. Bull Methodol Sociol 1997;55:5-17.
21. Rousson V, Gasser T, Seifert B. Assessing intrarater, interrater and test-retest reliability of continuous measurements. Statist Med 2002;21:3431-46. (Pubitemid 35314660)
22. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-74. (Pubitemid 8054849)
23. Cicchetti DV. Guidelines, criteria, and rules of thumb for evaluating normed and standardized assessment instruments in psychology. Psychol Assess 1994;64:284-90.
24. Haynes SN, Richard DCS, Kubany ES. Content validity in psychological assessment: a functional approach to concepts and methods. Psychol Assess 1995;7:238-47.
25. Polit DF, Beck CT, Owen SV. Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health 2007;30:459-67.
26. Lynn MR. Determination and quantification of content validity. Nurs Res 1986;35:382-5. (Pubitemid 17184381)
27. Squires A, Aiken LH, van den Heede K, et al. A systematic survey instrument translation process for multi-country, comparative health workforce studies. Int J Nurs Stud. Published Online First 23 Mar 2012. doi.org/10.1016/j.ijnurstu.2012.02.015.
28. McGeevey J, Orrevall Y, Petterson K, et al. Reflections on the process of translation and cultural adaption of an instrument to investigate taste and smell changes in adults with cancer. Scand J Car Sci 2012. In press.
29. Hyrkas K, Appelqvist-Schmidlechner K, Oksa L. Validating an instrument for clinical supervision using an expert panel. Int J Nurs Stud 2003;40:619-25. (Pubitemid 36875817)
30. Grant JS, Davis LL. Selection and use of content experts for instrument development. Res Nurs Health 1997;20:269-74.
31. Forbes LJL, Simon AE, Warburton F, et al. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? BJC 2012; in press.
32. Rizzo L, Brick JM, Park I. A minimally intrusive method for sampling persons in random digit dial surveys. Public Opin Q 2004;68:267-74. (Pubitemid 38919956)
33. Kim J-O, Mueller CW. Construction of factor scales. Factor analysis - statistical methods and practical issues. Newbury Park: Sage Publications Inc, 1978.
34. Champion VL, Skinner CS, Menon U, et al. A breast cancer fear scale: psychometric development. J Health Psychol 2004;9:753-62. (Pubitemid 39425361)
35. Powe BD. Cancer fatalism among elderly Caucasians and African Americans. Oncol Nurs Forum 1995;22:1355-9.